FDA Approved: XELPROS — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for XELPROS (latanoprost) by Sun Pharmaceutical Industries, expanding the product’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• XELPROS (LATANOPROST)

Snippet

SUPPL AP for XELPROS (LATANOPROST)